12:00 AM
 | 
Jul 30, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Ramucirumab regulatory update

The European Commission granted Orphan Drug designation for Eli Lilly's ramucirumab to treat gastric cancer and hepatocellular carcinoma. The human mAb VEGF receptor...

Read the full 93 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >